{
    "id": "f56140f5-edaf-4ede-a7a4-4506caaca572",
    "indications": "tadalafil tablets phosphodiesterase 5 ( pde5 ) inhibitor indicated treatment : erectile dysfunction ( ed ) ( 1.1 ) signs symptoms benign prostatic hyperplasia ( bph ) ( 1.2 ) ed signs symptoms bph ( ed/bph ) ( 1.3 ) tadalafil tablets used finasteride initiate bph treatment , recommended 26 weeks ( 1.4 ) .",
    "contraindications": "split tadalafil tablets ; entire dose taken .",
    "warningsAndPrecautions": "tadalafil tablets , usp supplied follows : 5 mg pale yellow , oval-shaped , film-coated tablets , debossed ‘ 09 ’ one side plain side . bottles 30 ndc 0480-2309-56 10 mg pale yellow , oval-shaped , film-coated tablets , debossed ‘ 10 ’ one side plain side . bottles 30 ndc 0480-2310-56 20 mg pale yellow , oval-shaped , film-coated tablets , debossed ‘ 11 ’ one side plain side . bottles 30 ndc 0480-2311-56",
    "adverseReactions": "tadalafil tablets patients using form organic nitrate contraindicated . tadalafil tablets shown potentiate hypotensive effect nitrates ( 4.1 ) . history known serious hypersensitivity reaction tadalafil adcirca ® ( 4.2 ) . guanylate cyclase ( gc ) stimulators , riociguat ( 4.3 ) .",
    "ingredients": [
        {
            "name": "TADALAFIL",
            "code": "742SXX0ICT"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "organization": "Teva Pharmaceuticals, Inc.",
    "name": "Tadalafil",
    "effectiveTime": "20250327",
    "indications_original": "Tadalafil tablets are a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) ( 1.1 ) the signs and symptoms of benign prostatic hyperplasia (BPH) ( 1.2 ) ED and the signs and symptoms of BPH (ED/BPH) ( 1.3 ) If tadalafil tablets are used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks ( 1.4 ).",
    "contraindications_original": "Do not split tadalafil tablets; entire dose should be taken.",
    "warningsAndPrecautions_original": "Tadalafil tablets, USP are supplied as follows: \n                        5 mg pale yellow, oval-shaped, film-coated tablets, debossed with ‘09’ on one side and plain on the other side.\n                        Bottles of 30                                                               NDC 0480-2309-56\n                        10 mg pale yellow, oval-shaped, film-coated tablets, debossed with ‘10’ on one side and plain on the other side.\n                        Bottles of 30                                                               NDC 0480-2310-56\n                        20 mg pale yellow, oval-shaped, film-coated tablets, debossed with ‘11’ on one side and plain on the other side.\n                        Bottles of 30                                                               NDC 0480-2311-56",
    "adverseReactions_original": "Administration of tadalafil tablets to patients using any form of organic nitrate is contraindicated. Tadalafil tablets were shown to potentiate the hypotensive effect of nitrates ( 4.1 ). History of known serious hypersensitivity reaction to tadalafil or ADCIRCA ® ( 4.2 ). Administration with guanylate cyclase (GC) stimulators, such as riociguat ( 4.3 )."
}